FDA WARNING_LETTER - Sanderlin, Damien MD - July 18, 2012
FDA WARNING_LETTER for Sanderlin, Damien MD on July 18, 2012. Product: Biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA WARNING_LETTER for Sanderlin, Damien MD on July 18, 2012. Product: Biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Sanderlin, Damien MDInspection Date
July 18, 2012
Product Type
Biologics
ID: 78811fb0-3473-463e-93d6-3fab4b41c1f3
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox